FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

6331011000036104: Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
2957641000168117 Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
2957651000168115 Vistide 375 mg/5 mL injection, 5 mL vial en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) has manufactured dose form injection true Inferred relationship Some
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) has Australian BoSS cidofovir true Inferred relationship Some 1104205264
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) Is a trade product unit of use true Inferred relationship Some
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) Is a Vistide true Inferred relationship Some
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) Is a cidofovir 375 mg/5 mL injection, vial true Inferred relationship Some
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) has manufactured dose form concentrated injection false Inferred relationship Some
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) has unit of use vial true Inferred relationship Some 1104205265
Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) has intended active ingredient cidofovir true Inferred relationship Some 1104205264

Inbound Relationships Type Active Source Characteristic Refinability Group
Vistide 375 mg/5 mL injection, 5 mL vial has TPUU True Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) Inferred relationship Some 1
Vistide 375 mg/5 mL injection, 5 mL vial has TPUU True Vistide (cidofovir 375 mg / 5 mL) injection, 5 mL vial (trade product unit of use) Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start